Clinical trials
Cardiovascular Diseases trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
253 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 14 |
| 2010 | 9 |
| 2011 | 11 |
| 2012 | 22 |
| 2013 | 13 |
| 2014 | 10 |
| 2015 | 10 |
| 2016 | 13 |
| 2017 | 10 |
| 2018 | 11 |
| 2019 | 15 |
| 2020 | 11 |
| 2021 | 11 |
| 2022 | 12 |
| 2023 | 11 |
| 2024 | 17 |
| 2025 | 13 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 130 |
| Recruiting | 31 |
| Unknown status | 30 |
| Terminated | 25 |
| Active, not recruiting | 24 |
| Not yet recruiting | 6 |
| Enrolling by invitation | 3 |
| Withdrawn | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 18 |
| Abbott Medical Devices | 10 |
| AstraZeneca | 9 |
| Heinrich-Heine University, Duesseldorf | 8 |
| Boston Scientific Corporation | 7 |
| GlaxoSmithKline | 7 |
| Medtronic Vascular | 7 |
| Edwards Lifesciences | 6 |
| RWTH Aachen University | 6 |
| Eli Lilly and Company | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 253 |
| Heart Diseases | 54 |
| Vascular Diseases | 34 |
| Heart Failure | 33 |
| Hypertension | 24 |
| Coronary Artery Disease | 23 |
| Diabetes Mellitus, Type 2 | 20 |
| Myocardial Infarction | 18 |
| Heart Valve Diseases | 17 |
| Atherosclerosis | 15 |
Trials
Showing 26 to 50 of 253. Each trial links to its page on Pharma Observatory.
153 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.